Published in Public Health Rep on March 16, 1993
Retracted Profile of Clients Tested HIV Positive in a Voluntary Counseling and Testing Center of a District Hospital, Udupi, South Kannada. Indian J Community Med (2008) 2.99
Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J (2006) 1.88
Delayed access to HIV diagnosis and care: Special concerns for the Southern United States. AIDS Care (2006) 1.52
Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Rep (1996) 1.30
Retracted Profile of Clients Tested HIV Positive in a Voluntary Counseling and Testing Center of a District Hospital, Udupi. Indian J Community Med (2009) 1.24
Using motivational interviewing in HIV field outreach with young African American men who have sex with men: a randomized clinical trial. Am J Public Health (2010) 1.01
Rapid Point-of-Care Testing for Detection of HIV and Clinical Monitoring. ISRN AIDS (2013) 0.88
Rapid Tests versus ELISA for Screening of HIV Infection: Our Experience from a Voluntary Counselling and Testing Facility of a Tertiary Care Centre in North India. ISRN AIDS (2014) 0.86
The outreach-assisted model of partner notification with IDUs. Public Health Rep (1998) 0.84
Returning for HIV Test Results: A Systematic Review of Barriers and Facilitators. Int Sch Res Notices (2016) 0.77
Provision of test results and posttest counseling at STD clinics in 24 health departments: U.S., 2007. Public Health Rep (2012) 0.77
Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage. Open Forum Infect Dis (2015) 0.75
Clients without health insurance at publicly funded HIV counseling and testing sites: implications for early intervention. Public Health Rep (1995) 0.75
Temporal trends in reasons for and result of HIV-testing among women in Rome, Italy. Eur J Epidemiol (1998) 0.75
Perception of risk. Science (1987) 17.91
Issues in the perception of AIDS risk and risk reduction activities by black and Hispanic/Latina women. Am Psychol (1988) 3.35
AIDS-related risk perception and sexual behaviour among sexually transmitted disease clinic attenders. Int J STD AIDS (1991) 2.27
The use of epidemiologic data for personal risk assessment in health hazard/health risk appraisal programs. J Chronic Dis (1983) 1.89
Perceived risk, real risk: social science and the art of probabilistic risk assessment. Science (1988) 1.43
Psychosocial predictors of people who fail to return for their HIV test results. AIDS (1990) 1.31
Women without health insurance. Links between access, poverty, ethnicity, and health. West J Med (1988) 1.27
HIV prevention for adolescents: utility of the Health Belief Model. AIDS Educ Prev (1991) 1.14
Organization of adolescent health services. Study group report. J Adolesc Health Care (1988) 1.06
Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ (2001) 8.76
Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA (1991) 7.35
Performance indicators for primary care groups: an evidence based approach. BMJ (1998) 6.97
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature (2000) 6.54
Preferences of patients for patient centred approach to consultation in primary care: observational study. BMJ (2001) 6.17
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
The chorio-allantoic membrane of the developing chick as a medium for the cultivation and histopathologic study of pathogenic fungi. Am J Pathol (1941) 4.64
23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet (2000) 4.23
Gain of function mutations in p53. Nat Genet (1993) 4.19
Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ (2001) 4.18
Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A (1997) 4.10
The Chorioallantoic Membrane of Chick Embryos and Its Response to Inoculation with Some Mycobacteria. Am J Pathol (1942) 4.02
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg (1996) 3.76
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics (2000) 3.48
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity (2001) 3.43
Studies on the fractionation of mucosal homogenates from the small intestine. Biochem J (1965) 3.37
The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol (1986) 3.36
Isolation and characterization of influenza A viruses from avian species in Hong Kong. Bull World Health Organ (1977) 3.17
Multiple adenovirus serotypes use alpha v integrins for infection. J Virol (1994) 2.86
Persistence of Hong Kong influenza virus variants in pigs. Science (1977) 2.72
Relationship between trauma center volume and outcomes. JAMA (2001) 2.56
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol (2002) 2.46
CAISSON DISEASE WITH SPECIAL REFERENCE TO THE BONES AND JOINTS: REPORT OF TWO CASES. Ann Surg (1940) 2.44
On-site, rapid HIV testing with same-day results and counseling. AIDS (1997) 2.44
Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (2009) 2.36
Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ (2001) 2.35
GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron (1998) 2.34
Overnight calls in primary care: randomised controlled trial of management using nurse telephone consultation. BMJ (1999) 2.32
Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA (2000) 2.31
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25
Validation study of a diary for use in acute lower respiratory tract infection. Fam Pract (2001) 2.24
Importance of lead selection in QT interval measurement. Am J Cardiol (1988) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicators. Qual Health Care (2000) 2.16
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. Proc Natl Acad Sci U S A (1998) 2.09
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br J Cancer (1984) 2.05
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Ann Oncol (2007) 2.03
Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res (2001) 2.00
Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial. BMJ (2000) 1.99
Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med (1996) 1.93
Six cases of gamma-D myelomatosis. Lancet (1966) 1.92
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
POLYAMINES, RNA SYNTHESIS, AND STREPTOMYCIN LETHALITY IN A RELAXED MUTANT OF E. coli STRAIN 15 TAU. Proc Natl Acad Sci U S A (1967) 1.82
Demonstration of cell-surface antigens on chemically induced tumors. Ann N Y Acad Sci (1971) 1.78
Yersinia enterocolitica O:3 infections in infants and children, associated with the household preparation of chitterlings. N Engl J Med (1990) 1.78
Psychosocial, lifestyle, and health status variables in predicting high attendance among adults. Br J Gen Pract (2001) 1.76
Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem (2001) 1.73
THE CHORIO-ALLANTOIC MEMBRANE OF THE DEVELOPING CHICK AS A MEDIUM FOR THE CULTIVATION AND HISTOPATHOLOGIC STUDY OF PATHOGENIC FUNGI. Science (1939) 1.71
Quality assurance of HIV prevention counseling in a multi-center randomized controlled trial. Project RESPECT Study Group. Public Health Rep (1996) 1.70
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
Centers for Disease Control. Enteroviral disease in the United States, 1970-1979. J Infect Dis (1982) 1.69
Promoting early HIV diagnosis and entry into care. AIDS (1999) 1.68
The "in vivo" production of "new" influenza A viruses. I. Genetic recombination between avian and mammalian influenza viruses. Virology (1971) 1.66
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65
Nucleotide sequence of a chromosomal mercury resistance determinant from a Bacillus sp. with broad-spectrum mercury resistance. J Bacteriol (1989) 1.64
Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis (1994) 1.63
Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Toxicol Appl Pharmacol (1997) 1.61
Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol (1995) 1.61
Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol. Int J Tuberc Lung Dis (2011) 1.60
Doses to critical organs following radiotherapy and concomitant imaging of the larynx and breast. Br J Radiol (2007) 1.58
Performance of a rapid, on-site human immunodeficiency virus antibody assay in a public health setting. J Clin Microbiol (1995) 1.58
Fowl plague virus from man. J Infect Dis (1970) 1.56
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet (1997) 1.55
Coated vesicles from rat liver and calf brain contain lysosomal enzymes bound to mannose 6-phosphate receptors. J Biol Chem (1983) 1.54
Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology (2007) 1.53
Measles spread in medical settings: an important focus of disease transmission? Pediatrics (1987) 1.48
Hematopoietic defects in mice lacking the sialomucin CD34. Blood (1996) 1.46
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44
Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr (2001) 1.44
Battling the biomedical information explosion: a plan for implementing a quality filtered database. Med Ref Serv Q (1989) 1.44
Management of stage II seminoma. J Clin Oncol (1998) 1.43
Local toxicity with subcutaneous methadone. Experience of two centers. Pain (1991) 1.43
Isolation and structure elucidation of Chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp. J Am Chem Soc (2001) 1.43
Evaluation of a proposed method for representing drug terminology. Proc AMIA Symp (1999) 1.42
Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis (2003) 1.41
Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. Br J Cancer (1984) 1.40
Plasma membrane water permeability of cultured cells and epithelia measured by light microscopy with spatial filtering. J Gen Physiol (1997) 1.39
Health and the World Trade Organization. N Z Med J (2000) 1.39
Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol (1985) 1.38
The popliteal artery and its branches: embryologic basis of normal and variant anatomy. AJR Am J Roentgenol (1988) 1.31
Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. Br J Cancer (1981) 1.31
Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. Br J Cancer (1984) 1.31
Structuring HIV prevention service delivery systems on the basis of social science theory. J Community Health (1992) 1.29
Core RNA polymerase and promoter DNA interactions of purified domains of sigma N: bipartite functions. J Mol Biol (1995) 1.29
No association between hepatitis C and B-cell lymphoma. Hepatology (1999) 1.28
Studies on the origin of pandemic influenza. IV. Selection and transmission of "new" influenza viruses in vivo. Virology (1974) 1.28
Epidural butorphanol or morphine for the relief of post-cesarean section pain: ventilatory responses to carbon dioxide. Anesth Analg (1987) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Increasing empathy among medical students. Med Educ (1989) 1.27
The "in vivo" production of "new" influenza viruses. 3. Isolation of recombinant influenza viruses under simulated conditions of natural transmission. Virology (1973) 1.26
The in vivo production of "new" influenza A viruses. II. In vivo isolation of "new" viruses. Virology (1972) 1.26